An increasingly recognized cause of dysphagia in patients with severe atopic dermatitis

Clinical and Experimental Dermatology

Volumn 36, Issue 2, 2011, Pages 206-207

  Al Niaimi, F ^a   Yell, J ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 5; MEPOLIZUMAB; MONTELUKAST; PROTON PUMP INHIBITOR;

ADULT; ATOPIC DERMATITIS; CASE REPORT; DRUG SUBSTITUTION; DYSPHAGIA; EOSINOPHIL COUNT; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS BIOPSY; GASTROSCOPY; HEARTBURN; HELPER CELL; HEMATEMESIS; HISTOPATHOLOGY; HUMAN; LETTER; MALE; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADULT; DEGLUTITION DISORDERS; DERMATITIS, ATOPIC; EOSINOPHILIC ESOPHAGITIS; HUMANS; MALE;

EID: 79951589341     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03903.x     Document Type: Letter

References (5)

1. Furuta GT, Liacouras CA, Collins MH et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133: 1342-63.
2. Collins MH, Blanchard C, Abonia JP et al. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol 2008; 6: 621-9.
3. Gupte AR, Draganov PV. Eosinophilic esophagitis. World J Gastroenterol 2009; 15: 17-24.
4. Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol 2006; 18: 211-7.
5. Stein ML, Collins MH, Villanueva JM et al. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 2006; 118: 1312-9.